Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$125,895,921
+$23,858,965 QoQ
Shares Held
2,624,472
-0.6% QoQ
Ownership
0.456%
of shares outstanding
% of Portfolio
7.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 11%
Shared 89%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Regal Partners Ltd holds $126,068,514 across 2 Biotechnology names. RPRX ranks #1 (99.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
2,624,472 | $125,895,921 | |
| 2 | RADX |
Radiopharm Theranostics Ltd
|
40,138 | $172,593 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $125,895,921 | 2,624,472 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $102,036,956 | 2,640,708 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $50,631,245 | 1,435,126 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $48,467,411 | 1,345,196 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $44,701,310 | 1,435,956 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $36,631,237 | 1,435,956 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,314,332 | 1,177,601 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $31,053,338 | 1,177,601 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $29,149,945 | 959,827 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||